Literature DB >> 23423177

Current status of photodynamic therapy for bile duct cancer.

Tae Yoon Lee1, Young Koog Cheon, Chan Sup Shim.   

Abstract

The most common form in bile duct cancers is a highly desmoplastic cancer with a growth pattern characterized by periductal extension and infiltration. The prognosis of bile duct cancers, especially hilar cholangiocarcinoma, is limited by tumor spread along the biliary tree leading to refractory obstructive cholestasis, cholangitis, and liver failure. Although biliary endoprosthesis improves occlusion rates and reduces the number of therapeutic interventions, median survival time is not ameliorated. Photodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photosensitizing agent in combination with laser irradiation of a distinct wavelength. Tumor ablation with PDT combined with biliary stenting reduces cholestasis and significantly improves median survival time in selected patients with bile duct cancers.

Entities:  

Keywords:  Bile duct neoplasms; Cholangiocarcinoma; Endoprosthesis; Photodynamic therapy; Photosensitizing agents

Year:  2013        PMID: 23423177      PMCID: PMC3572349          DOI: 10.5946/ce.2013.46.1.38

Source DB:  PubMed          Journal:  Clin Endosc        ISSN: 2234-2400


  46 in total

1.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

Review 2.  Cholangiocarcinoma: current concepts and insights.

Authors:  Gregory J Gores
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

3.  Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival.

Authors:  F Berr; M Wiedmann; A Tannapfel; U Halm; K R Kohlhaw; F Schmidt; C Wittekind; J Hauss; J Mössner
Journal:  Hepatology       Date:  2000-02       Impact factor: 17.425

4.  Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma.

Authors:  Franz Ludwig Dumoulin; Thomas Gerhardt; Sybille Fuchs; Christian Scheurlen; Michael Neubrand; Günter Layer; Tilman Sauerbruch
Journal:  Gastrointest Endosc       Date:  2003-06       Impact factor: 9.427

5.  Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study.

Authors:  Marianne E J Ortner; Karel Caca; Frieder Berr; Jochen Liebetruth; Ulrich Mansmann; Dominik Huster; Winfried Voderholzer; Guido Schachschal; Joachim Mössner; Herbert Lochs
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

6.  Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.

Authors:  David J Rea; Manuel Munoz-Juarez; Michael B Farnell; John H Donohue; Florencia G Que; Brian Crownhart; Dirk Larson; David M Nagorney
Journal:  Arch Surg       Date:  2004-05

7.  Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study.

Authors:  Mehdi Kaassis; Jean Boyer; Rémi Dumas; Thierry Ponchon; Dimitri Coumaros; Richard Delcenserie; Jean-Marc Canard; Jacques Fritsch; Jean-François Rey; Pascal Burtin
Journal:  Gastrointest Endosc       Date:  2003-02       Impact factor: 9.427

8.  Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.

Authors:  Marcus Wiedmann; Karel Caca; Frieder Berr; Ingolf Schiefke; Andrea Tannapfel; Christian Wittekind; Joachim Mössner; Johann Hauss; Helmut Witzigmann
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

9.  Novel bacteriochlorine for high tissue-penetration: photodynamic properties in human biliary tract cancer cells in vitro and in a mouse tumour model.

Authors:  Michael Oertel; Stanislaw I Schastak; Andrea Tannapfel; Ralf Hermann; Ulrich Sack; Joachim Mössner; Frieder Berr
Journal:  J Photochem Photobiol B       Date:  2003-10-15       Impact factor: 6.252

10.  Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma.

Authors:  Tae Yoon Lee; Young Koog Cheon; Chan Sup Shim; Young Deok Cho
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

View more
  9 in total

Review 1.  Radiological interventions in malignant biliary obstruction.

Authors:  Kumble Seetharama Madhusudhan; Shivanand Gamanagatti; Deep Narayan Srivastava; Arun Kumar Gupta
Journal:  World J Radiol       Date:  2016-05-28

Review 2.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

Review 3.  Palliation: Hilar cholangiocarcinoma.

Authors:  Mahesh Kr Goenka; Usha Goenka
Journal:  World J Hepatol       Date:  2014-08-27

4.  Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma.

Authors:  A Schmidt; M Bloechinger; A Weber; J Siveke; S von Delius; C Prinz; W Schmitt; R M Schmid; B Neu
Journal:  United European Gastroenterol J       Date:  2016-02-03       Impact factor: 4.623

5.  Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum.

Authors:  Mangal S Mahajan; Srikanth Moorthy; Sreekumar P Karumathil; R Rajeshkannan; Ramchandran Pothera
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

Review 6.  Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies.

Authors:  E Una Cidon
Journal:  Clin Med Insights Oncol       Date:  2016-05-12

7.  Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy.

Authors:  Ruud Weijer; Mans Broekgaarden; Massis Krekorian; Lindy K Alles; Albert C van Wijk; Claire Mackaaij; Joanne Verheij; Allard C van der Wal; Thomas M van Gulik; Gert Storm; Michal Heger
Journal:  Oncotarget       Date:  2016-01-19

8.  Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.

Authors:  Ruud Weijer; Mans Broekgaarden; Rowan F van Golen; Esther Bulle; Esther Nieuwenhuis; Aldo Jongejan; Perry D Moerland; Antoine H C van Kampen; Thomas M van Gulik; Michal Heger
Journal:  BMC Cancer       Date:  2015-12-26       Impact factor: 4.430

9.  Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids.

Authors:  Anne-Laure Bulin; Mans Broekgaarden; Tayyaba Hasan
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.